ABVC BioPharma Analyst Ratings
ABVC BioPharma Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/16/2022 | — | Maxim Group | Downgrades | Buy → Hold |
| 日期 | 上/下行 | 分析師公司 | 价格目標變更 | 評級變更 | 上一頁/目前評分 |
|---|---|---|---|---|---|
| 11/16/2022 | — | 美心集團 | 降級 | 購買 → 持有 |
What is the target price for ABVC BioPharma (ABVC)?
ABVC 生物製藥（ABVC）的目標價格是多少？
The latest price target for ABVC BioPharma (NASDAQ: ABVC) was reported by Maxim Group on November 16, 2022. The analyst firm set a price target for $0.00 expecting ABVC to fall to within 12 months (a possible -100.00% downside). 1 analyst firms have reported ratings in the last year.
美心集團於 2022 年 11 月 16 日公布了 ABVC 生物製藥（納斯達克股票代碼：ABVC）的最新價格目標。該分析師公司將價格目標設定為 0.00 美元，預計 ABVC 將在 12 個月內跌至 12 個月內（下行可能為 -100.00％）。1 家分析師公司在去年報告了評級。
What is the most recent analyst rating for ABVC BioPharma (ABVC)?
ABVC 生物製藥（ABVC）的最新分析師評級為何？
The latest analyst rating for ABVC BioPharma (NASDAQ: ABVC) was provided by Maxim Group, and ABVC BioPharma downgraded their hold rating.
ABVC 生物製藥（納斯達克股票代碼：ABVC）的最新分析師評級由美心集團提供，ABVC 生物製藥將其持有評級下調。
When is the next analyst rating going to be posted or updated for ABVC BioPharma (ABVC)?
ABVC 生物製藥（ABVC）的下一個分析師評級何時公佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of ABVC BioPharma, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for ABVC BioPharma was filed on November 16, 2022 so you should expect the next rating to be made available sometime around November 16, 2023.
分析師進行了廣泛的研究，其中包括通過公共財務報表，與 ABVC BioHharma 的高管和客戶交談以及收聽盈利電話會議後到達股票評級。大多數分析師每三個月這樣做一次，因此您應該每年每家公司獲得 4 個評級。ABVC 生物製藥的最後評級於 2022 年 11 月 16 日提交，因此您應該期望下一個評級將在 2023 年 11 月 16 日左右的某個時間提供。
Is the Analyst Rating ABVC BioPharma (ABVC) correct?
分析師評級 ABVC 生物製藥（ABVC）是否正確？
While ratings are subjective and will change, the latest ABVC BioPharma (ABVC) rating was a downgraded with a price target of $0.00 to $0.00. The current price ABVC BioPharma (ABVC) is trading at is $0.76, which is out of the analyst's predicted range.
儘管評級是主觀的並且會發生變化，但最新的 ABVC 生物製藥（ABVC）評級降級，目標價格為 0.00 美元至 0.00 美元。目前的價格 ABVC 生物製藥（ABVC）的交易價格為 0.76 美元，超出了分析師的預測範圍。
譯文內容由第三人軟體翻譯。